Assignee
ARTIVILA BIOPHARMA
CN·0 granted patents·6 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
6 records- 0163US2025346613A1Boric acid proteasome inhibitor and use thereofARTIVILA BIOPHARMA·Filed 2023·Application pending·0 cites
- 0263US2025368633A1Azepine fused ring compound as ripk1 inhibitor and use thereofARTIVILA BIOPHARMA·Filed 2023·Application pending·0 cites
- 0360US2026021094A1Composition for improving the efficacy of hair growth active substance and preparation method thereofARTIVILA BIOPHARMA·Filed 2023·Application pending·0 cites
- 0459US2023414581A1Sarm1 enzyme activity inhibitor and use thereof in neurodegenerative diseasesARTIVILA BIOPHARMA·Filed 2021·Application pending·0 cites
- 0557US2024368168A1Sarm1 enzyme activity inhibitor and application thereofARTIVILA BIOPHARMA·Filed 2022·Application pending·0 cites
- 0654US2025073199A1Polymyxin Antibiotic Synergist and Anti-Gram-Negative Bacteria Pharmaceutical CompositionARTIVILA BIOPHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARTIVILA BIOPHARMA files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →